AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡Ό

MONTELUKAST SODIUM in Zimbabwe

9 products registered with MCAZ β€” 9 active

Brand / ProductReg. No.HolderStatusExpires
MONAST 10
TABLET; ORAL
2016/22.1.1/5148HETERO LABS LTDactive12 Feb 2030
BREATHEZY
TABLET; ORAL
2015/21.1.1/5032MSN LABORATORIES LTDactive2 Sept 2029
BREATHEZY CW 5
TABLET; ORAL
2015/21.1.1/5031MSN LABORATORIES LTDactive2 Sept 2029
MONTERA 10
TABLET, COATED; ORAL
2015/22.1.1/5041COSPHARM INVESTMENTS PVT LIMITEDactive31 Dec 2027
ASTHATOR 5
TABLET; ORAL
2015/22.1.1/5127TORRENT EXPORTS LTDactive31 Dec 2027
MONTEMAC 10
TABLET, COATED; ORAL
2026/22.1.1/7324MACLEODS PHARMACEUTICALS LIMITEDactive31 Dec 2027
ASTHATORIO
TABLET; ORAL
2015/22.1.1/5126TORRENT EXPORTS LTDactive31 Dec 2027
MONTERA 4
TABLET; ORAL
2015/22.1.1/5039COSPHARM INVESTMENTS PVT LIMITEDactive31 Dec 2027
MONTERA 5
TABLET, COATED; ORAL
2015/22.1.1/5040COSPHARM INVESTMENTS PVT LIMITEDactive31 Dec 2027

MONTELUKAST SODIUM β€” MCAZ Registration Details

MCAZ (Zimbabwe) has 9 registered products containing MONTELUKAST SODIUM, of which 9 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track MONTELUKAST SODIUM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Montelukast Sodium β€” Zimbabwe (MCAZ) | AfricaRegulatory